BRD4 and glioblastoma: Presently, numerous BRD4 inhibitors have been identified for their capacity to exert inhibitory effects on GBM through diverse pathways, both in vitro and in vivo, including JQ1 [46], OTX015 (MK-8628) [27], GEN987 [23].